Intervacc AB
IVACC | ST
Overview
Corporate Details
- ISIN(s):
- SE0009607252 (+1 more)
- LEI:
- 549300OICIVZBBZRNZ64
- Country:
- Sweden
- Address:
- Västertorpsvägen 135B, 129 44 Hägersten
- Website:
- https://intervacc.se/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Intervacc AB is a biotechnology company developing a new generation of vaccines for the animal health sector. The company's proprietary technology platform, based on research from the Karolinska Institutet and the Swedish University of Agricultural Sciences, utilizes recombinant protein fusions to create safe and effective vaccines. Its portfolio is led by Strangvac®, a vaccine for equine strangles. Through its subsidiary Nordvacc, Intervacc operates an established sales and marketing organization with a 30-year track record in the European market. By providing innovative alternatives to traditional treatments, Intervacc's vaccines play a role in improving animal welfare and contributing to the global fight against antibiotic resistance.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Intervacc AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Intervacc AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Intervacc AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-26 | Lennart Johansson | Other | Other | 813,474 | 691,452.90 SEK |
| 2025-02-21 | Lennart Johansson | Other | Other | 324,156 | 275,532.60 SEK |
